🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This proof of concept study is designed to evaluate the efficacy and safety...
Status
Terminated
Location
Addenbrookes Hospital
Start Date
2008-03
Trial ID
NCT00542269
Treatments Being Tested
Atrial Flutter \[AFL\] is a relatively frequent arrhythmia, considered as b...
Status
Terminated
Location
CHU de Brest
Start Date
2008-07
Trial ID
NCT00736294
The purpose of this study is * To characterize the pharmacokinetic profile...
Status
Completed
Location
Lambda Therapeutic Research Limited
Start Date
2005-10
Trial ID
NCT01164774
To demonstrate the efficacy and safety of aliskiren given to patients with ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2004-11
Trial ID
NCT00219089
Treatments Being Tested
This is a multicenter, randomized, double-blind, active-controlled, dose-ti...
Status
Completed
Location
Groupe Hospitalier Pitie-Salpêtrière - Institut de Cardiologie
Start Date
2019-06-04
Trial ID
NCT03715998
Treatments Being Tested
Primary objective: Mean values of systolic and diastolic office blood pres...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT00325806
Treatments Being Tested
Numerous clinical and experimental data show that the elective treatment of...
Status
Unknown
Location
University of Pavia
Start Date
2010-10
Trial ID
NCT01230034
There is no data about the effects of Renin angiotensin system blockage (RA...
Status
Completed
Location
Gulhane School of Medicine
Start Date
2008-01
Trial ID
NCT01703234
Treatments Being Tested
Study to determine the potential pharmacokinetic interaction of ramipril (a...
Status
Completed
Location
International Pharmaceutical Research Center
Start Date
2019-02-23
Trial ID
NCT04262765
Treatments Being Tested
Angiotensin converting enzyme inhibitors (ACE-I) are a group of blood press...
Status
Completed
Location
Wisconisn Alzheimer's Disease Research Center
Start Date
2009-04-09
Trial ID
NCT00980785